Please login to the form below

Not currently logged in
Email:
Password:

Eisai appoints Lynn Kramer chief clinical officer

Says newly created position will strengthen its research base

Lynn Kramer, EisaiEisai's US subsidiary has appointed Lynn Kramer to the newly created position of chief clinical officer of Eisai Product Creation Systems.

He will be responsible for the approval of protocol designs of studies and selection of study regions and clinical sites.

Eisai said the appointment, which will also see him provide oversight of the design of proof of concept (POC) Studies for each of Eisai's product creation units, would strengthen its clinical research.

In addition to his new responsibilities, Dr Kramer will continue to serve as president of Eisai's Neuroscience and General Medicine Product Creation Unit, a position he has held since 2009.

Dr Kramer joined Eisai in 2007 as executive vice president of global clinical research and his roles since then have included COO of Eisai Medical Research and president of the Scientific and Operational Clinical Support unit.

Prior to joining Eisai, Dr Krammer had already spent more two decades in the pharmaceutical industry, serving at companies such as PAR Pharmaceutical, Ciba Geigy and Novartis.

17th April 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....